2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study

Authors: M Esteve Pastor, F Marin, M Anguita, M Sanmartin, C Rafols, F Arribas Ynsaurriaga, G Baron Esquivas, V Barrios, J Cosin Sales, R Freixa Pamias, A Perez Cabeza, J M Vazquez Rodriguez, I Lekuona Goya,

Published: 2021-10-20

DOI: 10.1093/eurheartj/ehab724.2484

Source: Full article

2MACE score predicts cardiovascular adverse events in real-world atrial fibrillation patients under rivaroxaban therapy. Data from EMIR study

Abstract